Clinicopathologic and molecular disease prognostication for papillary thyroid cancer

Paolo Miccoli, Mario Miccoli, Alessandro Antonelli, Michele N. Minuto

Research output: Contribution to journalArticle

Abstract

Despite its increasing incidence over the last 30 years, the mortality rate of papillary thyroid cancer (PTC) has decreased significantly. Nevertheless, a minority of patients still present with an aggressive form of PTC that can lead to death, even after a prolonged period of survival. Many classifications exist that allow one to stratify the clinical risk of recurrence and death in patients with PTC; however, the parameters upon which they are established are pathological and molecular and, therefore, are revealed only after surgery. The preoperative identification of these aggressive variants of PTC would allow one to schedule a more aggressive operation (e.g., total thyroidectomy together with central and/or mono- or bi-lateral node dissections) in patients with high-risk PTC. This article reviews the parameters used most commonly to differentiate low-risk PTCs from their more aggressive variants and describes some of the newest molecular therapies for this latter group of tumors.

Original languageEnglish
Pages (from-to)1261-1275
Number of pages15
JournalExpert Review of Anticancer Therapy
Volume9
Issue number9
DOIs
Publication statusPublished - Sep 2009

Fingerprint

Factor IX
Thyroidectomy
Group Psychotherapy
Dissection
Appointments and Schedules
Papillary Thyroid cancer
Recurrence
Survival
Mortality
Incidence
Neoplasms

Keywords

  • Papillary thyroid cancer
  • Postoperative therapy
  • Prognostic factors
  • Surgery

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Clinicopathologic and molecular disease prognostication for papillary thyroid cancer. / Miccoli, Paolo; Miccoli, Mario; Antonelli, Alessandro; Minuto, Michele N.

In: Expert Review of Anticancer Therapy, Vol. 9, No. 9, 09.2009, p. 1261-1275.

Research output: Contribution to journalArticle

Miccoli, Paolo ; Miccoli, Mario ; Antonelli, Alessandro ; Minuto, Michele N. / Clinicopathologic and molecular disease prognostication for papillary thyroid cancer. In: Expert Review of Anticancer Therapy. 2009 ; Vol. 9, No. 9. pp. 1261-1275.
@article{55df0fce6a304d6fb712e4bd1db2b346,
title = "Clinicopathologic and molecular disease prognostication for papillary thyroid cancer",
abstract = "Despite its increasing incidence over the last 30 years, the mortality rate of papillary thyroid cancer (PTC) has decreased significantly. Nevertheless, a minority of patients still present with an aggressive form of PTC that can lead to death, even after a prolonged period of survival. Many classifications exist that allow one to stratify the clinical risk of recurrence and death in patients with PTC; however, the parameters upon which they are established are pathological and molecular and, therefore, are revealed only after surgery. The preoperative identification of these aggressive variants of PTC would allow one to schedule a more aggressive operation (e.g., total thyroidectomy together with central and/or mono- or bi-lateral node dissections) in patients with high-risk PTC. This article reviews the parameters used most commonly to differentiate low-risk PTCs from their more aggressive variants and describes some of the newest molecular therapies for this latter group of tumors.",
keywords = "Papillary thyroid cancer, Postoperative therapy, Prognostic factors, Surgery",
author = "Paolo Miccoli and Mario Miccoli and Alessandro Antonelli and Minuto, {Michele N.}",
year = "2009",
month = "9",
doi = "10.1586/ERA.09.92",
language = "English",
volume = "9",
pages = "1261--1275",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "9",

}

TY - JOUR

T1 - Clinicopathologic and molecular disease prognostication for papillary thyroid cancer

AU - Miccoli, Paolo

AU - Miccoli, Mario

AU - Antonelli, Alessandro

AU - Minuto, Michele N.

PY - 2009/9

Y1 - 2009/9

N2 - Despite its increasing incidence over the last 30 years, the mortality rate of papillary thyroid cancer (PTC) has decreased significantly. Nevertheless, a minority of patients still present with an aggressive form of PTC that can lead to death, even after a prolonged period of survival. Many classifications exist that allow one to stratify the clinical risk of recurrence and death in patients with PTC; however, the parameters upon which they are established are pathological and molecular and, therefore, are revealed only after surgery. The preoperative identification of these aggressive variants of PTC would allow one to schedule a more aggressive operation (e.g., total thyroidectomy together with central and/or mono- or bi-lateral node dissections) in patients with high-risk PTC. This article reviews the parameters used most commonly to differentiate low-risk PTCs from their more aggressive variants and describes some of the newest molecular therapies for this latter group of tumors.

AB - Despite its increasing incidence over the last 30 years, the mortality rate of papillary thyroid cancer (PTC) has decreased significantly. Nevertheless, a minority of patients still present with an aggressive form of PTC that can lead to death, even after a prolonged period of survival. Many classifications exist that allow one to stratify the clinical risk of recurrence and death in patients with PTC; however, the parameters upon which they are established are pathological and molecular and, therefore, are revealed only after surgery. The preoperative identification of these aggressive variants of PTC would allow one to schedule a more aggressive operation (e.g., total thyroidectomy together with central and/or mono- or bi-lateral node dissections) in patients with high-risk PTC. This article reviews the parameters used most commonly to differentiate low-risk PTCs from their more aggressive variants and describes some of the newest molecular therapies for this latter group of tumors.

KW - Papillary thyroid cancer

KW - Postoperative therapy

KW - Prognostic factors

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=71049183144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71049183144&partnerID=8YFLogxK

U2 - 10.1586/ERA.09.92

DO - 10.1586/ERA.09.92

M3 - Article

C2 - 19761430

AN - SCOPUS:71049183144

VL - 9

SP - 1261

EP - 1275

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 9

ER -